iNtRON Biotechnology, Inc. — Investor Relations & Filings
iNtRON Biotechnology, Inc. is a biotechnology company specializing in solutions for infectious diseases. Its core activities are centered on three main pillars: bio-new drugs, molecular diagnostics, and molecular biology reagents. The company's therapeutic pipeline focuses on developing novel treatments for drug-resistant super-bacteria, creating antibiotic alternatives and other bio-active agents to address the challenge of antimicrobial resistance (AMR). In its diagnostics division, iNtRON develops and manufactures detection kits and assays, primarily based on real-time PCR technology, for the rapid identification of infectious organisms. The company also provides a range of molecular reagents for research and has commercialized antibiotic alternative products for the animal health market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 반기보고서 (2024.06) | 2024-08-14 | Korean | |
| 기타시장안내 (업종변경 안내) | 2024-06-28 | Korean | |
| 주요사항보고서(자기주식취득신탁계약체결결정) | 2024-06-19 | Korean | |
| 분기보고서 (2024.03) | 2024-05-14 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2024-04-19 | Korean | |
| 정기주주총회결과 | 2024-03-21 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
13 filings
| |||||
| 8092498 | 반기보고서 (2024.06) | 2024-08-14 | Korean | ||
| 8114817 | 기타시장안내 (업종변경 안내) | 2024-06-28 | Korean | ||
| 8122140 | 주요사항보고서(자기주식취득신탁계약체결결정) | 2024-06-19 | Korean | ||
| 8139717 | 분기보고서 (2024.03) | 2024-05-14 | Korean | ||
| 8146688 | 주식등의대량보유상황보고서(일반) | 2024-04-19 | Korean | ||
| 8165379 | 정기주주총회결과 | 2024-03-21 | Korean | ||
| 8187050 | 감사보고서제출 | 2024-03-13 | Korean | ||
| 8187001 | 사업보고서 (2023.12) | 2024-03-13 | Korean | ||
| 8198353 | 주주총회소집공고 | 2024-03-06 | Korean | ||
| 8198343 | 의결권대리행사권유참고서류 | 2024-03-06 | Korean | ||
| 8223338 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2024-01-26 | Korean | ||
| 8223335 | 주주총회소집결의 | 2024-01-26 | Korean | ||
| 8223334 | 현금ㆍ현물배당결정 | 2024-01-26 | Korean | ||
|
2023
2 filings
| |||||
| 8239297 | [기재정정]분기보고서 (2023.09) | 2023-12-15 | Korean | ||
| 8239198 | 주주명부폐쇄기간또는기준일설정 | 2023-12-15 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
iNtRON Biotechnology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16429/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16429 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16429 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16429 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16429}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for iNtRON Biotechnology, Inc. (id: 16429)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.